CXCR antagonist Plerixafor 8HCl, Purity ≥98%

Cat. No.: X23-10-ZQ514

CXCR antagonist Plerixafor 8HCl, Purity ≥98%

Synonym: 155148-31-5; Plerixafor octahydrochloride; Plerixafor hcl; AMD 3100 octahydrochloride; Plerixafor 8HCl (AMD3100 8HCl); Sid 791; JM 3100; CXCR antagonist

  • CAS Number: 155148-31-5
  • Compound CID: 65014
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Plerixafor 8HCl, soluble in water and insoluble in DMSO and ethanol, is a chemokine receptor-4 antagonist. It targets CXCL12 mediated chemotaxis and CXCR4.
Molecular Weight
794.5
Molecular Formula
C28H54N8.8HCl
Targets
CXCL12 mediated chemotaxis: 5.7 nM; CXCR4: 44 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: Insoluble; Water: 91 mg/mL (114.54 mM); Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Plerixafor 8HCl can be used to investigate its use as a hematopoietic stem cell mobilizer in cancer therapy.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.